ENDOTOXIN shock was induced in 31 anaesthetized pigs by infusion of 5 lig/kg of Escbeicbia coli endotoxin (LPS) over 60 mtn into the superior mesenteric artery. Fifteen of these pigs died wRhin 30 min of the start of LPS infusion whereas the remaining 16 survived the experimental period of 2 h. In a group of nine pigs indomethacin (2 mg/kg, i.v.)was inected 20-25 rain after the start of LPS infusion at which time mean arterial blood pressure (MABP) had decreased below 40 mmHg indicating imminent death. Indomethacin immediately reversed the hypotension. In another group of five pigs, 2Ca-nitro L-arginine-methyl ester (L-NAME, 1 and 3 mg/kg)was iniected 10 and 5 min, respectively, before the expected death without any beneficial effect on the hypotension. Three rain after the last dose of L-NAME, indomethacin (2 mg/kg, i.v.) was iniected. In three animals the hypotension was reserved by indomethacin, although this beneficial effect was delayed in comparison with the LPStreated group not receiving L-NAME. Four pigs were pretreated with L-NAME, 3 mg/kg, i.v., 10 min prior to LPS tnfiton. All pretreated animals tended to die within 30 mtn of the start of the LPS infusion. Five rain before the expected death (20-25 rain after the start of LPS infusion) tndomethacin (2 mg/kg) was inected. In three of these animals indomethacin reversed hypotenston and prevented death. Interestingly, this rise in the MABP deveb oped very slowly. These results suggest that the beneficial effect of indomethacin in endotoxin shock might be related partially to interference with nitric oxide, which is not the only factor determining blood pressure levels during endotoxic shock.
Introduction
It is becoming increasingly clear that septic shock represents a generalized inflammatory reaction with the induction of a number of mediators similar to local inflammatory reactions. 1,' Endotoxin and other bacterial products also induce the production of powerful mediators like eicosanoids, platelet-activating factor and cytokines. Recently, nitric oxide (NO) has been suggested to be involved in the hypotension observed during endotoxin shock in dogs and rats. 4 .
Non-steroid anti-inflammatory drugs (NSAIDs) represent a rational approach to break up the chain of mediators because of their ability to inhibit the cyclooxygenase enzyme, and this action may account for the clinical effectiveness of NSAIDs. We have previously demonstrated that the administration of indomethacin during endotoxin shock prevented death and improved the shock state. The beneficial effect on blood pressure was rapid in onset, reaching its maximum with 60 s, indicating a direct vasoconstrictor effect.: Since However, this beneficial effect was markedly delayed compared with the group treated with LPS, but not receiving r-NAME.
Systemic haemodynamics: As depicted in Fig. 1 L-NAME (3 mg kg-1)
Indomethec:in (2 mg kg"+) .,ndomethecln ( Fig. 2A .
In Group IV, five animals tended to die within 30 min after the start of LPS, and t-NAME (1 and 3 mg/ kg), given 10 and 5 min, respectively, before the expected death, failed to prevent the drop in MABP (to 20 _+ 2 mmHg) and the increase in MPAP (to 39 + 4 mmHg) as well as the reduction in CO (to 1.0 _+ 0.1 1/min). Three min after the last administration of t-NAME, indomethacin (2 mg/kg) was injected. This treatment was effective in restoring MABP in only three of five animals. Furthermore, in contrast to the immediate reversal of MABP observed in pigs treated with LPS but not receiving t-NAME, a delay (4 +_ 1 min) was observed in the onset of the beneficial effect. MPAP declined after indomethacin treatment; CO was transiently elevated and then decreased to the same levels as in the untreated LPS-infused survivors ( Fig. 1B and 2B) .
In Group V, four animals pretreated with t-NAME (3 mg/kg) prior to LPS infusion, tended to die at or close to 30 rain after the start of the LPS infusion. Indomethacin, given 5 min before the expected death, reversed the serious hypotension in three of four animals and prevented death. However, the delay between the indomethacin injection and the recovery of blood pressure was longer than in LPStreated and/or t-NAME post-LPS treated groups (8 _+ 0.6 min vs 1 + 0.01 min and 4 + 0.6 min, respectively). Furthermore, this recovery developed more slowly (in 13.5 + 0.7 min instead of 60 s), a time that characterized the beneficial effect of indomethacin in pigs treated with LPS only. MPAP decreased after indomethacin treatment, whereas CO was transiently elevated and then decreased to a similar level as observed in the untreated LPS-infused survivors ( Fig.  lC and 2C ).
Discussion
The main findings in the present study are: (1) It may be argued that the inability of I.-NAME to restore blood pressure in LPS-treated pigs is due to the dose of t-NAME employed in this study. However the highest dose (3 mg/kg) was effective in blocking NO 15 Therefore, it seems likely that the expected rise in arterial blood pressure following blockade of NO synthesis is counteracted by the coincident fall in cardiac output due to pulmonary vasoconstriction in pigs. 13 The rapid increase in mean pulmonary arterial pressure and the consecutive decrease in cardiac output following LPS infusion were enhanced by any form of t-NAME treatment in the present experiments. These findings suggest that the vasodilator tone exerted by NO is important for maintaining lung perfusion in endotoxin shock, which view is further supported by the observation that the most pronounced NO induction following LPS can be found in the lung. 16 Interestingly, NO synthase activity in the aorta preceded the enzyme activity in the lung. 16 However, a negative inotropic effect of t-NAME, either directly on the myocardium or indirectly via coronary artery vasoconstriction contributing to the fall in cardiac output, cannot be excluded. 17, 8 A recent study demonstrates that cytokines, including tumour necrosis factor (TNF), induce a negative inotropic effect on the heart mediated by cardiac NO production. 19 In addition, hypotension induced by TNF administration in dogs has been shown to be reversed by NO synthase inhibition 2 suggesting that the hypotension might be caused by an excessive NO production. Furthermore, in our endotoxic shock model, in non-survivors a marked increase was detected in plasma concentrations of TNF and NO 2-(M6zes et al., unpublished observations), but not platelet-activating factor or eicosanoids. As hypotension following administration of either TNF or LPS occurred within 30 min, one may assume that NO might be produced by the constitutive NO synthase rather than the inducible isoform, since its induction requires 60-180 min. 6 Indeed, TNF has been reported to induce NO release within 5 min in the papillary muscle preparation. 19 These observations argue against an effect requiring gene transcription. Therefore, the negative inotropic effects of cytokines appear to result from enhanced activity of a constitutive NO synthase in myocardium. 19 Taking into account that NO seems to be responsible for the maintenance of the pulmonary circulation as well as the hypotension in endotoxin shock and that blockade of both isoforms of NO synthase may exacerbate the endotoxin shock due to the pulmonary insufficiency, the challenge is to restore blood pressure without suppression of the pulmonary circulation. The release of NO in the early and late phase of endotoxaemia is triggered by two distinct mechanisms; by activation of the constitutive and the inducible NO synthase isoforms, respectively. 16 It seems that with the use of non-selective NO synthase inhibitors, such as t-NAME and monomethyl-t-arginine (t-NMMA), the problem remains unsolved. 4,1a2 Selective inhibition of the inducible NO synthase has been advocated as a useful tool in the late phase of endotoxin shock. 11 In contrast, the enhanced formation of NO by the constitutive enzyme seems to account for the immediate hypotension in response to LPS 16 and a similar mechanism has been observed in haemorrhagic shock in anaesthetized rats. 22 Therefore, it is conceivable that the constitutive NO synthase should be blocked in the early phase of endotoxin shock. This view is supported by the observation that in the early phase of endotoxin shock the constitutive NO synthase is more abundantly present in the aorta than in the lung. 16 Consequently, the use of an inhibitor of the constitutive enzyme may reverse the hypotension without disrupting the pulmonary homeostasis.
In the present study, indomethacin reversed hypotension, elevated cardiac output and prevented death. This beneficial effect on blood pressure was rapid in onset, reaching its maximum in 60 s, implying that vasoconstriction seen after indomethacin may be due to the inhibition of a rapidly degrading potent vasodilator like NO. However, the rapid release of a potent vasoconstrictor cannot be excluded.
Nevertheless, our results demonstrate a long delay in the beneficial effect of indomethacin after the inhibition of NO synthesis; therefore, the release of a vasoconstrictor does not seem very likely. Furthermore, the observed delay in the beneficial effect of indomethacin seems to depend on the duration of inhibition of both NO synthases. Recently, we observed a significant reduction in plasma nitrite concentration following L-NAME (3 mg/kg) from 15 min to 120 min in pigs (M6zes et al., unpublished observations). Since NO synthesis inhibition is more pronounced after 15 min, it is conceivable that in L-NAME pretreated animals the reversal of the hypotension takes longer (20-25 min after L-NAME) than in L-NAME post-LPS treated animals (3-8 min after L-NAME) or in the absence of L-NAME in LPS-treated animals. However, it is to be noted that the experiments were performed in pentobarbitone anaesthetized animals and it has been shown that this type of anaesthesia may delay the onset of pressor responses tO L-NAME. 23 Hence it may be suggested that anaesthesia contributed in part to the more pronounced delay observed in L-NAME pretreated animals.
Apart from its cyclooxygenase inhibitory action indomethacin possesses other activities such as blocking calcium influx. 23"24 One possible explanation for the rapid restoration of blood pressure following indomethacin administration may be a selective inhibition of NO synthase. Since indomethacin inhibits Ca 2+ uptake, 24 the activity of the calciumdependent NO synthase may be reduced. This view is supported by the observation that NO release is reduced by indomethacin-isolated rabbit hearts following reperfusion 25 and that nifedipine, a calcium channel antagonist, inhibits the induction of NO synthase by LPS. 26 These observations suggest that the rapid beneficial effect of indomethacin on haemodynamics in endotoxic shock may be mediated by some reduction in NO production or release. However, one should keep in mind that indomethacin demonstrated its beneficial effect on the circulation after a certain delay following L-NAME treatment suggesting that NO is not the only factor determining the blood pressure during endotoxic shock.
Finally, by increasing the intracellular cAMP level, 24 indomethacin may alter the balance between cAMP and cGMP. Because of their opposing effects on the circulation and platelet aggregation, 27 the balance between cAMP and cGMP might be more important than the change in their respective levels. Since NO is known to elevate cGMP levels, this explanation also suggests some interference between indomethacin and NO.
In summary, regardless of the precise mechanism, indomethacin administration during the early phase of LPS-induced shock reversed hypotension, decreased pulmonary pressure and improved cardiac output. It should be noted that the effect of indomethacin on haemodynamics preceded the effective blockade of cyclooxygenase enzyme. Indomethacin was less effective after the inhibition of both NO synthases suggesting that the beneficial effect of indomethacin in endotoxin shock might be partly related to either selective inhibition of the (Cai+-dependent) NO synthase, to antagonism of NO itself or both. However, the observation that the beneficial effect of indomethacin was delayed after NO synthase inhibition and was less effective suggests that NO is not the only factor determining the hypotension during endotoxic shock.
